SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (22617)6/23/1998 10:30:00 AM
From: Flagrante Delictu  Read Replies (3) of 32384
 
Henry, In the Bloomberg commentary on the recent feat by LGND, it is mentioned that" Currently available steroidal progestins, which are most often used in HRT (hormone replacement therapy) & birth control, do not exhibit this ability to discern between tissues or cell types."

This new compound is a "pharmacopore", as were the recently discovered series of compounds active in the androgen arena. Can you tell us how a pharmacopore might be distinct from our other compounds & whether you think we might have a third class of compounds to be added to our quiver {IYWPTE} in addition to our IR & STAT/JAK targets.

P.S. I see that these compounds were discovered using the IR technology. It is also derived from quinoline as were the androgen compounds.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext